Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
Applications Due:
Closed
Federal
US Department of Health & Human Services (National Institutes of Health)
This funding opportunity supports researchers and developers in creating and advancing innovative devices aimed at treating Substance Use Disorders, with a focus on achieving FDA approval for new therapeutic interventions.
Description
The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities to develop neuromodulatory or neurophysiological devices that are safe and effective SUD treatments. The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs.
Eligibility
States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Native American tribal organizations, Nonprofits
Funding
Program Funding
Award Ceiling
Award Floor
Award Count
Timing
Posted Date
August 18, 2023
App Status
No Longer Accepting Applications
Funder
Funding Source
Source Type
Federal
Contact Name
NIH Grants Information
Contact Email
Contact Phone
--